Our CLIA-licensed, CAP-accredited clinical research sequencing laboratory provides end-to-end, high scale exome sequencing using our optimized workflow.
Dedicated project managers will work with you throughout the process to ensure delivery of data you can rely on for sensitive somatic variant detection.
Experimental planning
Sample prep
Sequencing
Data analysis
1. Gnirke et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nature Biotechnology 27, 182 – 189 (2009).
2. Fisher et al. A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biology 12:R1 (2011).
3. Cibulskis et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology 31, 213–219 (2013).
4. Allen et al. Whole-exome sequencing and clinical interpretation of FFPE tumor samples to guide precision cancer medicine. Nature Medicine 20. 682-8. (2014).
Copyright © 2023 Broad Institute. All Rights Reserved. Privacy Policy | Terms & Conditions
As part of our commitment to providing unsurpassed excellence in sequencing, the Broad Institute now offers services utilizing the improved capabilities of the Illumina® NovaSeq X platform.